Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Real-world study of guselkumab for psoriasis in mainland China
ChiCTR2000041398Phase 4Recruiting
- Sponsor
- Southern Medical University Dermatology Hospital
- Start
- Apr 2020
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of guselkumab in psoriasis, sponsored by Southern Medical University Dermatology Hospital. Primary endpoints: Psoriasis Area Severity Index at Week 16, Nail Psoriasis Severity Index at Week 16 and 1 more. Started Apr 2020; status: recruiting.
02
Drugs
guselkumab
03
Conditions
psoriasis
Beyond the preview
Go deeper on ChiCTR2000041398.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000041398.